Literature DB >> 8930327

Immunohistochemical distribution of metabotropic glutamate receptor subtypes mGluR1b, mGluR2/3, mGluR4a and mGluR5 in human hippocampus.

I Blümcke1, K Behle, B Malitschek, R Kuhn, T Knöpfel, H K Wolf, O D Wiestler.   

Abstract

The metabotropic glutamate receptors (mGluRs) can be classified into three families based on amino acid sequence homology, signal transduction mechanisms and pharmacological properties. Generally, class I mGluRs mediate an excitation of neurons while activation of class II and III mGluRs results in a depression of synaptic transmission. In this study we have analyzed the expression pattern of mGluRs in human hippocampus using a panel of polyclonal antibodies specific for mGluR1b, mGluR2/3, mGluR4a, and mGluR5. Immunoreactivity for mGluR1b and mGluR5, i.e., the subtypes representing class I mGluRs, was found in all hippocampal neurons. The mGluR1b antiserum stained perikarya and proximal dendrites, whereas immunoreactivity for mGluR5 was also detectable in the distal dendritic compartments. Immunoreactivity for mGluR2/3, members of class II mGluRs, was present in all principle neurons in the dentate gyrus as well as in the CA4, CA3 and CA2 regions. Pyramidal cells of the CA1 region exhibited only weak labeling for mGluR2/3. Glial cells were also mGluR2/3-immunoreactive. The reaction obtained with an antiserum directed against mGluR4a, a member of class III mGluRs, was confined to the mossy fiber projection field in CA3 stratum lucidum. These data demonstrate differential expression of mGluR variants in the human hippocampus and may provide an important basis for future studies of mGluRs under various neuropathological conditions such as temporal lobe epilepsy, ischemia and neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930327     DOI: 10.1016/0006-8993(96)00697-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

Review 1.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

Review 2.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction.

Authors:  M Foster Olive
Journal:  Curr Drug Abuse Rev       Date:  2009-01

3.  Coincidence detection and stress modulation of spike time-dependent long-term depression in the hippocampus.

Authors:  Pitt Niehusmann; Gabriel Seifert; Kristin Clark; Hasan C Atas; Inga Herpfer; Bernd Fiebich; Josef Bischofberger; Claus Normann
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

4.  The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus.

Authors:  Susan F Sonnenschein; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2020-07-14       Impact factor: 7.853

5.  Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields.

Authors:  Kimmo J Hatanpaa; Jack M Raisanen; Emily Herndon; Dennis K Burns; Chan Foong; Amyn A Habib; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2014-02       Impact factor: 3.685

6.  Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.

Authors:  E Tatarczyńska; A Klodzińska; E Chojnacka-Wójcik; A Palucha; F Gasparini; R Kuhn; A Pilc
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Developmental distribution pattern of metabotropic glutamate receptor 5 in prenatal human hippocampus.

Authors:  Pengbo Yang; Junfeng Zhang; Lingyu Zhao; Qian Jiao; Hui Jin; Xinli Xiao; Haixia Zhang; Ming Hu; Haixia Lu; Yong Liu
Journal:  Neurosci Bull       Date:  2012-12-07       Impact factor: 5.203

Review 8.  Therapeutic promise and principles: metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

9.  GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.

Authors:  Emilio R Garrido Sanabria; Krystyna M Wozniak; Barbara S Slusher; Asaf Keller
Journal:  J Neurophysiol       Date:  2003-08-13       Impact factor: 2.714

Review 10.  Sex differences in the glutamate system: Implications for addiction.

Authors:  L L Giacometti; J M Barker
Journal:  Neurosci Biobehav Rev       Date:  2020-03-12       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.